These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19608910)

  • 21. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of rotavirus vaccination on epidemiological dynamics in England and Wales.
    Atkins KE; Shim E; Pitzer VE; Galvani AP
    Vaccine; 2012 Jan; 30(3):552-64. PubMed ID: 22133508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.
    Marlow R; Muir P; Vipond B; Lyttle M; Trotter C; Finn A
    Euro Surveill; 2015; 20(48):30077. PubMed ID: 26675375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
    Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rotavirus seasonal distribution and prevalence before and after the introduction of rotavirus vaccine in a peri-urban community of Lima, Peru.
    Chang MR; Velapatiño G; Campos M; Chea-Woo E; Baiocchi N; Cleary TG; Ochoa TJ
    Am J Trop Med Hyg; 2015 May; 92(5):986-8. PubMed ID: 25778507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.
    Sahakyan G; Grigoryan S; Wasley A; Mosina L; Sargsyan S; Asoyan A; Gevorgyan Z; Kocharyan K; Avagyan T; Lopman B; Vanyan A; Khactatryan S; Parashar UD; Cortese MM
    Clin Infect Dis; 2016 May; 62 Suppl 2():S147-54. PubMed ID: 27059349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotavirus vaccination.
    Bjur KA; Jacobson RM
    Minerva Pediatr; 2009 Oct; 61(5):515-21. PubMed ID: 19794377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public health. Progress toward rotavirus vaccines.
    Parashar UD; Glass RI
    Science; 2006 May; 312(5775):851-2. PubMed ID: 16690845
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.
    Mpabalwani EM; Simwaka CJ; Mwenda JM; Mubanga CP; Monze M; Matapo B; Parashar UD; Tate JE
    Clin Infect Dis; 2016 May; 62 Suppl 2():S183-7. PubMed ID: 27059354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador.
    Yen C; Armero Guardado JA; Alberto P; Rodriguez Araujo DS; Mena C; Cuellar E; Nolasco JB; De Oliveira LH; Pastor D; Tate JE; Parashar UD; Patel MM
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S6-S10. PubMed ID: 21048524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.
    Nakagomi O; Iturriza-Gomara M; Nakagomi T; Cunliffe NA
    Expert Opin Biol Ther; 2013 Nov; 13(11):1613-21. PubMed ID: 24088009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy.
    Lopez AL; Raguindin PF; Silva MWT
    Hum Vaccin Immunother; 2019; 15(6):1260-1264. PubMed ID: 30513238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization.
    Sánchez-Uribe E; Esparza-Aguilar M; Parashar UD; Richardson V
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S133-9. PubMed ID: 27059347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales.
    Atchison C; Lopman B; Edmunds WJ
    Vaccine; 2010 Apr; 28(18):3118-26. PubMed ID: 20197142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001 to 2015.
    Getachew HB; Dahl RM; Lopman BA; Parashar UD
    Pediatr Infect Dis J; 2018 Sep; 37(9):943-948. PubMed ID: 29561514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    Ai CE; Steele M; Lopman B
    PLoS One; 2020; 15(2):e0228942. PubMed ID: 32059029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.